Home Insemination Kit Success Rates: What the Clinical Data Actually Shows

Published April 5, 2026 · 11 min read

By Dr. Priya Anand

Disclosure: MakeAMom manufactures home insemination kits reviewed in this article. We strive for factual accuracy and link to primary sources throughout. All clinical data and study references are cited independently.

Every insemination kit website quotes success rates, but the numbers are not always what they seem. Some brands cite their own studies. Others report cumulative user outcomes that span years and thousands of customers. A few cite no specific data at all, relying instead on the general body of ICI research to support their claims.

If you are comparing kits and trying to figure out which one actually gives you the best chance of getting pregnant, you deserve a clear-eyed look at the evidence. Here is what the actual clinical data says about each kit on the market, and the factors that matter far more than which box you open on insemination day.

What "Success Rate" Actually Means

Before comparing any numbers, you need to understand two fundamentally different ways success is measured in fertility, because brands use whichever framing makes their numbers look better.

Per-cycle rate is the probability of getting pregnant from a single menstrual cycle of insemination. For intracervical insemination (ICI) with proper ovulation timing, independent studies consistently place this at 10 to 15 percent. That number may sound low, but it is actually comparable to natural conception rates for couples having well-timed intercourse.

Cumulative rate is the probability of achieving pregnancy over multiple cycles. This is where the math becomes more encouraging. Over six well-timed ICI cycles, cumulative success rates reach 50 to 70 percent for women under 35 with no underlying fertility conditions. The cumulative rate is what most women should focus on, because it reflects the reality that conception often takes several attempts regardless of method.

When a brand quotes a success rate, always ask: is this per cycle or cumulative? Is it from one study or many? And who conducted the study? These distinctions change everything.

Mosie Baby's Claims

Mosie Baby is the most specific about their success rate data, citing a 28 percent per-cycle rate from a clinical study they registered on ClinicalTrials.gov (NCT04646291). This is a notable claim because it is nearly double the 10 to 15 percent per-cycle rate found in most independent ICI literature.

There are important caveats to understand. The study was conducted by Mosie Baby themselves, not by an independent research institution. The study measures intravaginal insemination (IVI) using their specific device, which is a slightly different method than traditional ICI. And 28 percent, while possible in a well-selected study population, is meaningfully higher than what the broader body of ICI research reports.

This does not mean the number is fabricated. It means the methodology matters. Study population, inclusion criteria, how ovulation timing was managed, and how success was defined all influence outcomes. A company-sponsored study with carefully selected participants may produce results that do not generalize to the broader population of women trying to conceive at home. For a detailed look at their kit, see our Mosie Baby review.

PherDal's Positioning

PherDal takes a different approach entirely. Named TIME Magazine's Invention of the Year, PherDal positions itself as a sterile, IUI-equivalent device designed by a Black woman OB-GYN to address racial disparities in fertility care. Their messaging focuses on the clinical-grade sterility of the device and its syringe-free design rather than on a specific per-cycle success rate.

PherDal does not prominently cite a specific success rate figure on their website or marketing materials. This is neither inherently good nor bad. It means they are not making claims they cannot substantiate, but it also means there is no PherDal-specific data to evaluate. Their outcomes would be expected to fall within the general ICI range of 10 to 15 percent per cycle, since the underlying method is the same.

Frida Fertility

Frida Fertility, an extension of the well-known Frida Baby brand, entered the insemination market with a kit that prioritizes approachable design and mainstream retail availability. Like PherDal, Frida does not cite a specific success rate for their device. Their marketing leans on the general efficacy of at-home insemination as a method rather than device-specific data.

For women who want to understand what FDA clearance means for insemination kits, it is worth noting that FDA clearance speaks to safety and manufacturing standards, not to efficacy or success rates.

MakeAmom's Data

MakeAmom reports over 12,800 pregnancies across all kits, including the BabyMaker, CryoBaby, and Impregnator. This is a user-reported figure, not a controlled clinical study, and MakeAmom is transparent about that distinction.

User-reported data has strengths and limitations. The strength is volume: 12,800 pregnancies across a real-world user base provides a meaningful signal that the products work for the population using them. The limitation is that user-reported data lacks the controls of a clinical study. There is no tracking of how many total users attempted and did not succeed, which means you cannot derive a per-cycle rate from this number alone.

What the number does tell you is that thousands of women have successfully conceived using these kits across a range of ages, fertility situations, and sperm sources, which is a meaningful data point when evaluating whether a product works in practice.

What the Independent Research Says

Setting aside brand-specific claims, the independent fertility literature provides the most reliable baseline for at-home insemination success. A study published in Human Reproduction (2006) found that ICI performed at home produced pregnancy rates comparable to clinic-based ICI, confirming that the setting itself does not significantly impact outcomes when technique and timing are correct.

The American Society for Reproductive Medicine (ASRM) recognizes ICI as a legitimate fertility method and provides guidelines for its use. Multiple independent studies converge on the same range: 10 to 15 percent per cycle with proper ovulation timing, and 50 to 70 percent cumulative over six cycles for women under 35.

The consistency of these numbers across studies, countries, and decades is actually reassuring. It means at-home ICI is a well-understood method with predictable outcomes, regardless of which specific device you use to perform it.

Success Rate Claims by Kit

The Factors That Actually Determine Success

Here is what the research consistently shows: the factors that determine whether you get pregnant dwarf the choice of insemination kit. Understanding and optimizing these variables will do far more for your chances than agonizing over which brand to buy.

Age. This is the single largest factor. Fertility declines significantly after 35 and more steeply after 40. A 28-year-old and a 40-year-old using the exact same kit with the exact same technique will have dramatically different per-cycle rates, and no kit can close that gap.

Ovulation timing accuracy. Inseminating within the 12 to 24-hour window after ovulation is the difference between a viable attempt and a wasted cycle. Using ovulation predictor kits (OPKs) and tracking your LH surge is not optional if you want to maximize your chances. Our guide on how many attempts per cycle covers optimal timing strategy in detail.

Sperm quality and motility. Whether you are using fresh sperm from a partner or frozen donor sperm, the quality of the sample matters enormously. Sperm count, motility (how well they swim), and morphology (their shape) all influence the probability of fertilization. If you are using frozen sperm, proper thawing technique preserves viability.

Number of attempts per cycle. Inseminating twice during your fertile window, once at the LH surge and once 12 to 24 hours later, significantly improves your odds compared to a single attempt. This is where the 6-month cost comparison becomes relevant, because the kit that allows you to afford more attempts per cycle may outperform a more expensive kit that limits you to one.

Underlying conditions. PCOS, endometriosis, blocked fallopian tubes, diminished ovarian reserve, and other conditions all reduce per-cycle rates regardless of which kit or method you use. If you have a diagnosed condition, factor that into your expectations and timeline.

Why Kit Choice Still Matters

If the kit itself is a minor variable in per-cycle success, why does it matter at all? Because the indirect effects of your kit choice compound over multiple cycles.

Comfort affects consistency. If the insemination process is uncomfortable, stressful, or awkward, you are less likely to follow through on the recommended two-attempts-per-cycle approach, and you are more likely to take breaks between cycles. A kit that feels comfortable and intuitive keeps you consistent, and consistency over six cycles is what drives cumulative success.

Cost affects the number of cycles you can afford. At-home insemination is a numbers game played over months. If a kit costs $100 per cycle and you can only afford three cycles, you have a lower cumulative probability than if a $40 kit lets you attempt six cycles. When comparing kits, calculate the total cost over six months, not just the sticker price of a single kit. See our best insemination kit guide for a full cost breakdown.

Specialization matters for specific situations. If you are using frozen donor sperm, a kit designed for frozen sperm (like the CryoBaby) includes the thawing equipment and calibrated syringes that a general-purpose kit does not. If you are dealing with vaginismus or discomfort, a kit with a slim, body-safe silicone applicator (like the BabyMaker) may make the difference between completing the process and abandoning it mid-cycle.

The Honest Answer

No kit gives you a significantly better per-cycle rate than another when technique and timing are equal. The independent research is clear on this point: ICI success rates are driven by biological factors, not by the specific device used to deposit sperm near the cervix.

What differs between kits is cost per cycle, comfort during the process, and how well they are designed for your specific situation. These factors matter because they determine how many well-timed, properly executed cycles you can complete, and that number is what ultimately determines your cumulative probability of success.

The smartest approach is to choose the kit that fits your budget, your sperm source, and your comfort level, then commit to six well-timed cycles before evaluating your results. That strategy, grounded in the actual clinical data, gives you the best chance of success regardless of which brand name is on the box.

Frequently Asked Questions

What is the success rate of Mosie Baby?

Mosie Baby claims a 28 percent per-cycle rate from their own clinical study registered on ClinicalTrials.gov (NCT04646291). This is notably higher than the 10 to 15 percent per-cycle rate found in independent ICI research. The study was conducted by Mosie Baby, not by an independent research institution, which is an important distinction when evaluating the data.

What is the success rate of at-home insemination?

Per-cycle success rates for at-home insemination are 10 to 15 percent when ovulation timing is accurate. Cumulative rates over six well-timed cycles reach 50 to 70 percent for women under 35 with no underlying fertility conditions. These figures come from multiple independent studies and are consistent across the fertility literature.

Does the insemination kit affect success rate?

Minimally. The three biggest factors in at-home insemination success are ovulation timing accuracy, the age of the person trying to conceive, and sperm quality and motility. The kit itself primarily affects comfort and affordability, which indirectly influence success by determining how many cycles you attempt and how consistently you follow through.

How many cycles of home insemination before seeing a doctor?

The American Society for Reproductive Medicine (ASRM) recommends six well-timed cycles if you are under 35, and three to four cycles if you are over 35, before consulting a reproductive endocrinologist. If you have known fertility conditions such as irregular cycles, PCOS, or endometriosis, consulting a doctor before beginning is advisable.

Related Articles

AT-HOME INSEMINATION

FDA-Cleared vs Non-FDA: Does It Matter?

FERTILITY & CONCEPTION

How Many Attempts Per Cycle?

PRODUCT REVIEWS

Mosie Baby Review: Pros, Cons & Alternatives